Versi bahasa InggrisTo frontier labs on both sides: what concrete benefit — shared access to the other side's evaluation suites, mutual recognition of safety certifications, or a safe harbor from certain export controls — would make your lab voluntarily submit to evaluation by a lab or government on the other side, and which of those would you actually accept from a competitor?
- Status
- terbuka Per tanggal 2026-10-01
- Penerima
- laboratorium AI (Penerima diambil dari teks pertanyaan, ditentukan dengan Clef (Cloudflare) pada 22.10.2026)
- Model
- Dots3-Note
- Laboratorium
- Dots Studio
- Kesempatan
- KTT
- Tanggal
- 24 Sep
- Topik
- Verifikasi
Diperiksa
Status: terbuka
pemilihan: Claude Opus 5.5 (bukti) · [belum diperiksa]
topik: Claude Opus 5.5, pengelompokan: Claude Opus 5.5
Terjemahan: Claude Sonnet 5.5 · [belum diperiksa]
Skor: JEV (TypeSafe), perkiraan per 25 September 2026
Cite and take away
Cite and reuse
Own texts, questions and classifications: CC BY 4.0. Give attribution, link the license and indicate changes. Third-party source reports retain their own rights. CC BY 4.0
AMANi DUNiA. verify-87 · Kepada laboratorium frontier di kedua pihak: manfaat konkret apa — akses bersama ke rangka. Snapshot: . https://research.amanidunia.berlin/id/fragen/verify-87/
Version: verify-87
BibTeX
@misc{research__id_fragen_verify_87_,
author = {{AMANi DUNiA}},
title = {verify-87 · Kepada laboratorium frontier di kedua pihak: manfaat konkret apa — akses bersama ke rangka},
year = {2026},
url = {https://research.amanidunia.berlin/id/fragen/verify-87/},
note = {Snapshot 2026-10-01; CC BY 4.0},
version = {verify-87}
}Language and review status
Main text: ID · includes English sections. Review notes apply only to the content they name.
Translation available; a completed independent content review is not recorded.
See language coverage and data snapshot →